Literature DB >> 15275334

Immunobiology of experimental cutaneous leishmaniasis.

G Milon1, G Del Giudice, J A Louis.   

Abstract

The study of the murine model of infection with Leishmania major is providing important insights into the understanding of the complex interactions between the host and intracellular pathogens. Using this model system, basic research is actively leading to the identification of host factors promoting or circumventing the development of immunity to L. major. Here, Geneviève Milon, Giuseppe Del Giudice and Jacques A. Louis review recent results related to the characterization of immunological host factors determining resistance and susceptibility to this parasite, and try to identify areas where further research is required for a better understanding of the complex events triggered by intracellular parasites within their hosts. Extrapolation to the human leishmaniases of the rapid advances made in this murine model of infection, should pave the way to the rational design of future immunoprophylactic and immunotherapeutic measures.

Entities:  

Year:  1995        PMID: 15275334     DOI: 10.1016/0169-4758(95)80200-2

Source DB:  PubMed          Journal:  Parasitol Today        ISSN: 0169-4758


  6 in total

1.  Bacterial lipoprotein-based vaccines induce tumor necrosis factor-dependent type 1 protective immunity against Leishmania major.

Authors:  Javier Cote-Sierra; Amin Bredan; Carmen M Toldos; Benoit Stijlemans; Lea Brys; Pierre Cornelis; Manuel Segovia; Patrick de Baetselier; Hilde Revets
Journal:  Infect Immun       Date:  2002-01       Impact factor: 3.441

2.  In vivo formation of electron paramagnetic resonance-detectable nitric oxide and of nitrotyrosine is not impaired during murine leishmaniasis.

Authors:  S Giorgio; E Linares; H Ischiropoulos; F J Von Zuben; A Yamada; O Augusto
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

3.  Comparative analysis of the tissue inflammatory response in human cutaneous and disseminated leishmaniasis.

Authors:  Marina Loyola Dantas; Juliana Menezes Gomes Cabral de Oliveira; Lucas Carvalho; Sara Timóteo Passos; Adriano Queiroz; Luiz Henrique Guimarães; Paulo Machado; Edgar Carvalho; Sérgio Arruda
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-03-05       Impact factor: 2.743

4.  Use of Optical Imaging Technology in the Validation of a New, Rapid, Cost-Effective Drug Screen as Part of a Tiered In Vivo Screening Paradigm for Development of Drugs To Treat Cutaneous Leishmaniasis.

Authors:  Diana Caridha; Sandi Parriot; Thomas H Hudson; Thierry Lang; Franklyn Ngundam; Susan Leed; Jenell Sena; Michael Harris; Michael O'Neil; Richard Sciotti; Lisa Read; Herve Lecoeur; Mark Hickman; Max Grogl
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

Review 5.  Route map for the discovery and pre-clinical development of new drugs and treatments for cutaneous leishmaniasis.

Authors:  Diana Caridha; Brian Vesely; Katrien van Bocxlaer; Byron Arana; Charles E Mowbray; Sima Rafati; Silvia Uliana; Rosa Reguera; Mara Kreishman-Deitrick; Richard Sciotti; Pierre Buffet; Simon L Croft
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2019-06-20       Impact factor: 4.077

6.  IL-23 and IL-27 Levels in Macrophages Collected from Peripheral Blood of Patients with Healing Vs Non-Healing Form of Cutaneous Leishmaniasis.

Authors:  S Tolouei; K Ghaedi; A Khamesipour; M Akbari; M Baghaei; Sj Hasheminia; M Narimani; Sh Hejazi
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.